Product Images Depo-subq Provera
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 22 images provide visual information about the product associated with Depo-subq Provera NDC 0009-4709 by Pharmacia & Upjohn Company Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure A - depo subq provera 01
The text describes a prefilled syringe needle with a safety shield for protection. The needle has a diameter of 3/8" and a specified length.*
Figure B - depo subq provera 02
Figure C - depo subq provera 03
Figure D - depo subq provera 04
Figure E - depo subq provera 05
Figure F - depo subq provera 06
Figure G - depo subq provera 07
Figure H - depo subq provera 08
Figure I - depo subq provera 09
Figure J - depo subq provera 10
Figure K - depo subq provera 11
Figure L - depo subq provera 12
Figure M - depo subq provera 13
This is a collection of references to studies that have investigated the relationship between the use of DMPA (a type of birth control) and the risk of developing H- (not enough information provided to identify what H- means). The studies were conducted by Lee et al. in 1987, Paul et al. in 1989, WHO in 1991, Shapiro et al. in 2000, and Lie et al. in 2012. The data presented shows odds ratios for DMPA use greater than or equal to 12 months for different age groups. The odds ratios presented are measures of the increased risk for DMPA use, and the values shown in parentheses are the confidence intervals for those odds ratios.*
Figure N - depo subq provera 14
Figure O - depo subq provera 15
Chemical Structure - depo subq provera 16
Figure P - depo subq provera 17
This data appears to be a chart or graph showing values at different time intervals. The values decrease over time, with the highest being 150 and the lowest being 30. The other characters appear to be decorative lines or symbols. The text "quw/Bu)" is not readable, likely due to a scanning error.*
Figure Q - depo subq provera 18
Logo - depo subq provera 19
This text is a statement indicating that the product is distributed by Pharmacia & Upjohn Co, which is a division of Pfizer Inc located in NY.*
Logo - depo subq provera 20
This is a statement indicating that a company called Pharmacia & Upjohn Co, which is a division of Pfizer Inc located in NY, NY 10017 is responsible for distribution.*
PRINCIPAL DISPLAY PANEL - 0.65 mL Syringe Label - depo subq provera 21
This is a medication called Depo-Suba which is a subcutaneous injection of medroxyprogesterone acetate. It is supplied in a 0.65 mL single-dose syringe with a concentration of 104 mg/mL. The manufacturer is Pharmacia & Upjohn Co. It should be stored at room temperature and not refrigerated. There is a lot/expiry number listed but it is not available in the text provided.*
PRINCIPAL DISPLAY PANEL - 0.65 mL Syringe Carton - depo subq provera 22
This is a description of a medication called Depo-SubQ Provera 104, which comes in a prefilled syringe. Shake the medication before use. The medication contains various chemicals, such as medroxyprogesterone acetate and sodium phosphate. The dosage and usage guidelines are not provided in the text. The medication should be stored at controlled room temperature, between 20°C and 25°C, and should not be refrigerated. Contact details for pfizer.com are provided for more information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.